Maximilian Schmeding, Ulf Peter Neumann, Gero Puhl, Marcus Bahra, Ruth Neuhaus, Peter Neuhaus – 24 April 2007 – Today, hepatitis C virus (HCV) is the leading cause for liver transplantation (LT) and viral recurrence is almost universal. It has been suggested that viral replication within the transplanted tissue might be increased in organs of reduced size such as LD grafts. In the current literature the data is controversial, with many studies lacking routine liver biopsies.

Shin Hwang, Sung‐Gyu Lee, Deok‐Bog Moon, Chul‐Soo Ahn, Ki‐Hun Kim, Young‐Joo Lee, Tae‐Yong Ha, Gi‐Won Song – 24 April 2007 – Salvage liver transplantation has been performed for recurrent hepatocellular carcinoma (HCC) or deterioration of liver function after primary liver resection. Because prior liver resection per se is an unfavorable condition for living donor liver transplantation (LDLT), we assessed the technical feasibility of LDLT after prior hepatectomy, and we compared the outcome of salvage LDLT with that of primary LDLT in HCC patients.

Farzan Filsoufi, Sacha P. Salzberg, Parwis B. Rahmanian, Thomas D. Schiano, Hussien Elsiesy, Anthony Squire, David H. Adams – 10 April 2007 – Liver cirrhosis is a major risk factor in general surgery. Few studies have reported on the outcome of cardiac surgery in these patients. Herein we report our recent experience in this high‐risk patient population according to the Child‐Turcotte‐Pugh classification and Model for End‐Stage Liver Disease (MELD) score.

Sébastien Dharancy, Jeanne Boitard, Thomas Decaens, Géraldine Sergent, Emmanuel Boleslawski, Christophe Duvoux, Claire Vanlemmens, Carole Meyer, Jean Gugenheim, François Durand, Olivier Boillot, Nicole Declerck, Alexandre Louvet, Valérie Canva, Olivier Romano, Olivier Ernst, Philippe Mathurin, François René Pruvot – 10 April 2007 – Supraselective transarterial chemoembolization (STACE) more efficiently targets chemotherapy delivered via the feeding arterial branches of the tumor than does conventional transarterial chemoembolization (TACE).

Robert G. Gish – 29 March 2007

Olga Tucker, Narendra Battula, Pauline Kane, John Karani, Nigel Heaton, Paolo Muiesan – 29 March 2007

Markus Golling, Cosima Jahnke, Hamidreza Fonouni, Rezvan Ahmadi, Renate Urbaschek, Raoul Breitkreutz, Peter Schemmer, Thomas W. Kraus, Martha M. Gebhard, Markus W. Büchler, Arianeb Mehrabi – 29 March 2007 – The liver function and perfusion following brain death is mainly influenced by the sympathetic nerves and hormones. We examined the specific influence of surgical liver denervation on systemic and hepatic perfusion parameters, bowel ischemia and oxidative stress in hemodynamically stable BD and control (living donor [LD]) pigs.

Paul P.C. Poyck, Ruurdtje Hoekstra, Albert C.W.A. van Wijk, Chiara Attanasio, Fulvio Calise, Robert A.F.M. Chamuleau, Thomas M. van Gulik – 29 March 2007 – The selection of a cell type for bioartificial liver (BAL) systems for the treatment of patients with acute liver failure is in part determined by issues concerning patient safety and cell availability. Consequently, mature porcine hepatocytes (MPHs) have been widely applied in BAL systems. The success of clinical BAL application systems is, however, largely dependent on the functionality and stability of hepatocytes.

Hiroto Egawa, Katsuyuki Ohmori, Hironori Haga, Hiroaki Tsuji, Kimiko Yurugi, Aya Miyagawa‐Hayashino, Fumitaka Oike, Akinari Fukuda, Jun Yoshizawa, Yasutsugu Takada, Koichi Tanaka, Taira Maekawa, Kazue Ozawa, Shinji Uemoto – 29 March 2007 – Although the effectiveness of rituximab has been reported in ABO blood group (ABO)‐incompatible (ABO‐I) organ transplantation, the protocol is not yet established.

Makoto Osawa, Yutaka Ito, Toyohiro Hirai, Rie Isozumi, Shunji Takakura, Yasuhiro Fujimoto, Yoshitsugu Iinuma, Satoshi Ichiyama, Koichi Tanaka, Michiaki Mishima – 29 March 2007 – Invasive aspergillosis (IA) is a severe complication of liver transplantation. Risk factors for IA after deceased donor liver transplantation (DDLT) have been presented in several reports, but are not well established for living donor liver transplant recipients. Here, a retrospective case‐control study was performed.